Notice of Results

RNS Number : 4591F

Microsaic Systems plc

21 February 2018

 

21 February 2018

Microsaic Systems plc

("Microsaic", "Microsaic Systems" or the "Company")

Notice of Results

Microsaic Systems plc (AIM: MSYS), the developer of chip-based mass spectrometry instruments, announces that the Company will be reporting final results for the 12 months ended 31 December 2017 on Monday 5 March 2018.

Enquiries:
Microsaic Systems plc Glenn Tracey, CEO Bevan Metcalf, FD	[phone]
N+1 Singer (Nominated Adviser & Broker) Shaun Dobson Liz Yong	[phone]
IFC Advisory (Financial PR) Graham Herring Heather Armstrong Florence Chandler	[phone]

About Microsaic Systems

Microsaic Systems plc (AIM: MSYS) is a high technology company developing chip-based, bench-top and point-of-analysis mass spectrometry ("MS") instruments that are designed to improve the efficiency of pharmaceutical R&D. The Company is working with established global life science companies to co-develop new solutions to improve productivity in the development of small molecule and novel biologic (peptides, antibodies) medicines. MS is a powerful method of analysis to enable earlier decision making relating to product identification, purity and bioactivity, and is the analytical technique of choice for biochemists across many industry sectors.

Microsaic's core product, the 4000 MiD(R), is one of the smallest MS systems in the world, retaining the functionality of larger conventional MS systems, is easier to use by non-specialists, consumes less energy and has lower running costs. For more information, please go to www.microsaic.com.

 

END

 

 

NORLFFIFFEIIFIT